Sands Capital Alternatives as of March 31, 2026
Portfolio Holdings for Sands Capital Alternatives
Sands Capital Alternatives holds 21 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nu Hldgs Ord Shs Cl A (NU) | 22.3 | $94M | 6.5M | 14.37 | |
| Klaviyo Com Ser A (KVYO) | 16.9 | $71M | 3.6M | 19.46 | |
| Spyglass Pharma Com Shs | 15.4 | $65M | 2.5M | 25.91 | |
| Beta Bionics (BBNX) | 8.8 | $37M | 3.7M | 10.02 | |
| Inhibikase Therapeutics Com New (IKT) | 5.2 | $22M | 13M | 1.68 | |
| Coupang Cl A (CPNG) | 4.5 | $19M | 1.0M | 18.88 | |
| Samsara Com Cl A (IOT) | 4.2 | $18M | 560k | 31.69 | |
| Doordash Cl A (DASH) | 4.0 | $17M | 111k | 150.15 | |
| Bioage Labs (BIOA) | 3.3 | $14M | 786k | 17.49 | |
| 10x Genomics Cl A Com (TXG) | 2.4 | $10M | 482k | 21.23 | |
| Datadog Cl A Com (DDOG) | 2.4 | $10M | 86k | 118.05 | |
| Acumen Pharmaceuticals (ABOS) | 2.1 | $8.8M | 3.7M | 2.36 | |
| Toast Cl A (TOST) | 1.9 | $8.0M | 302k | 26.51 | |
| Tarsus Pharmaceuticals (TARS) | 1.4 | $6.0M | 85k | 70.15 | |
| Servicetitan Shs Cl A (TTAN) | 1.4 | $5.7M | 90k | 63.46 | |
| Monday SHS (MNDY) | 1.1 | $4.7M | 68k | 69.11 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $3.2M | 725k | 4.47 | |
| Snowflake Com Shs (SNOW) | 0.7 | $3.1M | 20k | 150.82 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.7 | $3.0M | 2.1M | 1.39 | |
| Candel Therapeutics (CADL) | 0.5 | $2.0M | 406k | 4.90 | |
| Figma Class A Com Stk (FIG) | 0.1 | $387k | 18k | 21.14 |
